University of Kansas Research Connects Estrogen-Based Hormone Therapy to Sustained Brain Health and Cognitive Aging

As women age, maintaining cognitive function becomes a primary health objective. With women making up nearly two-thirds of Alzheimer’s disease patients in the USA, understanding the biological factors that influence brain health is more critical than ever. Recent research from the University of Kansas has shed light on a significant protective factor: estrogen-based hormone therapy. By examining the lifetime accumulation of reproductive hormone exposure, KU researchers are providing new insights into cognitive aging and potential strategies for preserving brain structure and function over time.

Understanding the Connection Between Reproductive Hormones and the Brain

For decades, the medical community has recognized that reproductive hormones play a role far beyond fertility. Estrogen, in particular, is a critical component for various bodily systems, including the central nervous system. According to Amber Watts, a professor of psychology at the University of Kansas and a co-lead author of a recent study, estrogen is fundamentally neuroprotective.

“Estrogen is beneficial for white matter integrity. It helps protect neurons and strengthens neural connections. It is also important for vascular function,” Watts explains. This means that the hormone does not merely support reproductive health; it actively maintains the structural and functional integrity of the brain. When estrogen levels fluctuate or drop—such as during menopause—the brain can become more vulnerable to the physiological changes associated with cognitive aging.

Schedule a free consultation to learn more about how hormonal changes affect cognitive health.

Key Findings from the University of Kansas Study on Cognitive Aging

Published in the peer-reviewed journal NeuroImage, the study analyzed 459 women aged 65 to 80. The researchers investigated three primary sources of lifetime hormone exposure to determine their impact on late-life brain health:

• Use of hormonal birth control: Utilization of estrogen-based contraceptives during young adulthood.
• Use of menopausal hormone therapy (MHT): The use of hormone therapies during the menopausal transition.
• Natural hormone exposure: The duration of natural ovarian hormone production, estimated by the age at which menopause naturally occurred.

The findings were clear. Older women who had used hormonal birth control in their younger years were more likely to possess larger brain volumes in regions vital to memory, cognition, and information processing. Furthermore, women who experienced menopause at a later age—thus benefiting from a longer period of natural hormone exposure—exhibited a thicker cortex in multiple brain regions that are particularly vulnerable to Alzheimer’s disease. A thicker cortex generally indicates healthier brain structure and a lower risk of neurodegeneration.

Explore our related articles for further reading on women’s health and neurology.

The Cumulative Effect of Estrogen Exposure Over a Lifetime

What makes this University of Kansas study distinct is its comprehensive look at a woman’s entire reproductive lifespan. Historically, much of the scientific focus was placed exclusively on menopausal hormone therapy, often ignoring the hormonal fluctuations of early adulthood.

“When your brain is first developing, say in adolescence, there are a lot of hormone changes happening then. People haven’t really given much thought to what implications that might have for brain health in the long term,” Watts noted. The research suggests that it is the lifetime accumulation of estrogen—from birth control in early adulthood to MHT during menopause—that provides a cumulative protective effect against cognitive decline. This long-view approach shifts the paradigm from treating menopause as an isolated event to viewing it as one stage in a continuum of hormonal influence on the brain.

Rethinking the Controversy Around Menopausal Hormone Therapy in the USA

The conversation surrounding hormone therapy in the USA has been fraught with confusion for over two decades. In 2002, the Women’s Health Initiative (WHI) released results that broadly linked hormone therapy with negative health outcomes, prompting a massive shift away from prescribing these treatments. Patients and doctors alike were understandably cautious.

However, Watts and her colleagues argue that the 2002 findings required significant context that was largely lost in public translation. “There’s been a controversy over hormone therapy use… its results scared everybody out of using estrogen therapy,” Watts said. “Since then, there’s been a lot of revisiting of those findings and discovering that there were some problems with them and that they didn’t apply to everyone.”

Modern research, including this study from the University of Kansas, aligns with a growing consensus that hormone therapy can offer substantial benefits for brain health when utilized appropriately. For instance, the study and related literature indicate that women who underwent early surgical removal of the ovaries definitively benefited from hormone therapy, as it replaced the hormones their bodies were abruptly deprived of, thereby protecting their neurological health.

Submit your application today to participate in upcoming menopause and cognitive health studies.

Practical Implications for Women’s Health Care and Brain Health

The implications of this research extend far beyond the laboratory. Because the Centers for Disease Control and Prevention notes that most American women of childbearing age use some form of birth control, understanding the long-term effects of these medications is a matter of widespread public health importance.

Watts emphasizes that both healthcare providers and patients need to shift their perspective on reproductive care. “When they think about taking birth control for the purpose of either regulating their cycles or for contraception, I don’t think what people are thinking about is, ‘How will this affect my health later?’” This lack of long-term foresight means that women may be missing out on a broader understanding of how their reproductive choices impact their cognitive aging trajectory.

Actionable Steps for Patients and Health Care Providers

For women navigating reproductive health decisions, these findings offer an opportunity to have more informed, forward-looking conversations with their doctors. Key considerations include:

• Evaluating lifetime hormone exposure: Recognize that decisions made in your 20s and 30s regarding birth control may intersect with menopausal health decisions in your 50s. Keep a record of your reproductive health history.
• Personalized menopausal care: Avoid blanket rejections of hormone therapy based on outdated studies. Instead, discuss individual risk factors, such as the timing of menopause or a history of ovarian surgery, with a qualified specialist.
• Focusing on brain health proactively: View vascular and neurological health as intertwined with reproductive health, rather than as completely separate medical silos. Estrogen’s role in vascular function directly impacts blood flow to the brain.

Have questions? Write to us to connect with specialists in cognitive aging.

The Future of Brain Health and Hormone Research at the University of Kansas

Despite the clear findings regarding cognitive aging, the intersection of reproductive endocrinology and neurology remains significantly under-researched. Women’s health has historically been understudied in clinical trials, leading to gaps in knowledge that researchers at the University of Kansas are actively working to fill.

Watts and her team at the KU Alzheimer’s Disease Research Center are currently recruiting participants for new menopause-related studies. The high level of public interest in this topic underscores a critical need for more robust data. “It’s a topic that women are very excited about, and every time I talk about it, I have a line of people waiting to ask me more questions,” Watts shared.

As the population ages in the USA, the prevalence of Alzheimer’s disease and other dementias is expected to rise, placing an immense burden on families and the healthcare system. Identifying modifiable risk factors—such as the strategic use of estrogen-based hormone therapy—could play a vital role in reducing the societal and individual burden of cognitive decline. By continuing to explore how hormones protect the aging brain, institutions like the University of Kansas are paving the way for more nuanced, effective, and personalized approaches to women’s healthcare.

Share your experiences with hormone therapy and cognitive health in the comments below.